3D Culture of Circulating Tumor Cells for Evaluating Early Recurrence and Metastasis in Patients with Hepatocellular Carcinoma
暂无分享,去创建一个
Xiang Fei | Bin Sun | Cong-li Hu | Yan-Jun Zhang | Xiaofeng Zhang | Hai Zhang | Chunguang Li | Hai Zhang
[1] Ying Zhu,et al. Circulating tumor cells in cancer patients: developments and clinical applications for immunotherapy , 2020, Molecular Cancer.
[2] C. Ye,et al. Heterogeneous immunogenomic features and distinct escape mechanisms in multifocal hepatocellular carcinoma. , 2019, Journal of hepatology.
[3] M. Omata,et al. Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review , 2019, International journal of molecular sciences.
[4] A. Jemal,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.
[5] Nam-Trung Nguyen,et al. Circulating tumor microemboli: Progress in molecular understanding and enrichment technologies. , 2018, Biotechnology advances.
[6] G. Wang,et al. Circulating Tumor Cells with Stem-Like Phenotypes for Diagnosis, Prognosis, and Therapeutic Response Evaluation in Hepatocellular Carcinoma , 2018, Clinical Cancer Research.
[7] Jacquelyn O. Russell,et al. Wnt/β-Catenin Signaling in Liver Development, Homeostasis, and Pathobiology. , 2018, Annual review of pathology.
[8] Lydia Giannitrapani,et al. Surveillance Program for Diagnosis of HCC in Liver Cirrhosis: Role of Ultrasound Echo Patterns , 2017, BioMed research international.
[9] Lei Chen,et al. Midkine promotes hepatocellular carcinoma metastasis by elevating anoikis resistance of circulating tumor cells , 2017, Oncotarget.
[10] Kai Qu,et al. MCM7 promotes cancer progression through cyclin D1-dependent signaling and serves as a prognostic marker for patients with hepatocellular carcinoma , 2017, Cell Death & Disease.
[11] Manal M. Hassan,et al. Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinoma , 2016, Oncotarget.
[12] Mustafa Yilmaz,et al. Effect of adipocyte-secreted factors on EpCAM+/CD133+ hepatic stem cell population. , 2016, Biochemical and biophysical research communications.
[13] J. Massagué,et al. Metastatic colonization by circulating tumour cells , 2016, Nature.
[14] Minetta C. Liu,et al. Circulating tumor cells are associated with poor overall survival in patients with cholangiocarcinoma , 2016, Hepatology.
[15] Lei Chen,et al. pERK/pAkt phenotyping in circulating tumor cells as a biomarker for sorafenib efficacy in patients with advanced hepatocellular carcinoma , 2015, Oncotarget.
[16] G. Gores,et al. Liver cancer: Approaching a personalized care. , 2015, Journal of hepatology.
[17] Lei Chen,et al. Improved method increases sensitivity for circulating hepatocellular carcinoma cells. , 2015, World journal of gastroenterology.
[18] V. Mazzaferro,et al. Early Hepatocellular Carcinoma on the Procrustean Bed of Ablation, Resection, and Transplantation , 2014, Seminars in Liver Disease.
[19] Sridhar Ramaswamy,et al. Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis , 2014, Cell.
[20] J. Shrager,et al. Circulating Tumor Microemboli Diagnostics for Patients with Non–Small-Cell Lung Cancer , 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[21] Sridhar Ramaswamy,et al. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility , 2014, Science.
[22] J. Bruix,et al. Treatment of Hepatocellular Carcinoma , 2014, Digestive Diseases.
[23] E. Lianidou,et al. Circulating tumor cells as promising novel biomarkers in solid cancers , 2014, Critical reviews in clinical laboratory sciences.
[24] C. Lovitt,et al. Miniaturized three-dimensional cancer model for drug evaluation. , 2013, Assay and drug development technologies.
[25] Kam M. Hui,et al. MiR-214 Targets β-Catenin Pathway to Suppress Invasion, Stem-Like Traits and Recurrence of Human Hepatocellular Carcinoma , 2012, PloS one.
[26] Z. Yin,et al. Circulating tumor cells in hepatocellular carcinoma: detection techniques, clinical implications, and future perspectives. , 2012, Seminars in oncology.
[27] Sridhar Ramaswamy,et al. RNA sequencing of pancreatic circulating tumour cells implicates WNT signaling in metastasis , 2012, Nature.
[28] G. Barrière,et al. Epithelial Mesenchymal Transition: A New Insight into the Detection of Circulating Tumor Cells , 2012, ISRN oncology.
[29] J. Bruix,et al. Plasma Biomarkers as Predictors of Outcome in Patients with Advanced Hepatocellular Carcinoma , 2012, Clinical Cancer Research.
[30] Yong‐Nyun Kim,et al. Anoikis Resistance: An Essential Prerequisite for Tumor Metastasis , 2012, International journal of cell biology.
[31] Caroline Dive,et al. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] L. Ellis,et al. A novel platform for detection of CK+ and CK- CTCs. , 2011, Cancer discovery.
[33] D. Planchard,et al. Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer , 2011, British Journal of Cancer.
[34] S. Dent,et al. USP22 regulates cell proliferation by deubiquitinating the transcriptional regulator FBP1 , 2011, EMBO reports.
[35] Yu Zhang,et al. Isolation of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Using a Novel Cell Separation Strategy , 2011, Clinical Cancer Research.
[36] Dai Fukumura,et al. Malignant cells facilitate lung metastasis by bringing their own soil , 2010, Proceedings of the National Academy of Sciences.
[37] K. Sugamura,et al. Characterization of the epithelial cell adhesion molecule (EpCAM)+ cell population in hepatocellular carcinoma cell lines , 2010, Cancer science.
[38] Larry Norton,et al. Tumor Self-Seeding by Circulating Cancer Cells , 2009, Cell.
[39] M. Emmert-Buck,et al. Identification of EpCAM as a molecular target of prostate cancer stroma. , 2009, The American journal of pathology.
[40] N. Meropol. The significance of circulating tumor cells as prognostic markers for colon cancer. , 2009, Clinical advances in hematology & oncology : H&O.
[41] X. Wang,et al. EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. , 2009, Gastroenterology.
[42] K. Pienta,et al. Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer , 2008, Clinical Cancer Research.
[43] Michael Morse,et al. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[44] Liang Tang,et al. Wnt/beta-catenin signaling contributes to activation of normal and tumorigenic liver progenitor cells. , 2008, Cancer research.
[45] Curt Balch,et al. Identification and characterization of ovarian cancer-initiating cells from primary human tumors. , 2008, Cancer research.
[46] Wenjun Guo,et al. The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.
[47] Jin Woo Kim,et al. EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma. , 2008, Cancer research.
[48] Brigitte Rack,et al. Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System , 2007, Clinical Cancer Research.
[49] Danila Coradini,et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. , 2005, Cancer research.
[50] H. Clevers,et al. Wnt signalling in stem cells and cancer , 2005, Nature.
[51] Alison Stopeck,et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. , 2004, The New England journal of medicine.
[52] Y. Hannun,et al. EpCAM Is Overexpressed in Breast Cancer and Is a Potential Target for Breast Cancer Gene Therapy , 2004, Cancer Research.
[53] G. Michalopoulos,et al. Beta-catenin is temporally regulated during normal liver development. , 2004, Gastroenterology.
[54] P. Ruck,et al. Ep‐CAM in malignant liver tumours , 2000, The Journal of pathology.
[55] C. Lim,et al. Prospective Molecular Profiling of Circulating Tumor Cells from Patients with Melanoma Receiving Combinatorial Immunotherapy. , 2019, Clinical chemistry.
[56] A. Desmoulière,et al. Hepatic stellate cells reversibly express alpha-smooth muscle actin during acute hepatic ischemia. , 1997, Transplantation proceedings.